Endocrinology News

More than half of adults with hypothyroidism have self-reported high levels of negative feelings and social withdrawal, or a type D personality, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

ATLANTA — New results from the TACTiC trial show the promise of technology to help individuals appropriately determine if they qualify for statin therapy without a prescription.

Women are not universally at risk for depressive symptoms during menopause transition, but providers should be aware of risk factors and treat mental health disorders promptly, according to a review published in The Lancet.

ATLANTA — In the TACT2 trial, chelation therapy reduced levels of lead in the blood but did not improve cardiovascular outcomes for adults with diabetes and a prior heart attack.

ATLANTA — Adults with obesity, HF with preserved ejection fraction and type 2 diabetes saw marked improvements in HF symptoms and physical function with semaglutide 2.4 mg compared with placebo, despite less than typical weight loss.

ATLANTA — Monthly administration of subcutaneous olezarsen substantially reduced triglyceride levels compared with placebo among patients with predominantly moderate hypertriglyceridemia and elevated CV risk, according to new phase 2 data.

ATLANTA — In the EMPACT-MI trial, empagliflozin treatment soon after an acute MI did not significantly lower risk for HF hospitalization or death from any cause compared with placebo among patients with increased risk for HF.

“If you think it’s expensive to hire a professional to do the job, wait until you hire an amateur.”

Nonbinary youths report more depression and are more likely to attempt self-harm than binary transgender youths, according to study findings published in LGBT Health.

Abnormal laboratory results are rare among adolescents receiving gender-affirming hormone therapy, according to study results published in Pediatrics.